Next-Generation Molecular Markers: Challenges, Applications and Future Perspectives-Reference-Cited by-同舟云学术

Next-Generation Molecular Markers: Challenges, Applications and Future Perspectives

Published:2019-01-29 Issue: Volume: Page:494-530
ISSN:
Container-title:Genomics and Clinical Diagnostics
language:
Short-container-title:

Author:

Verma Mukesh¹,Barh Debmalya²,Hassan Syed Shah³

Affiliation:

1. Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute (NCI), National Institutes of Health (NIH), 9609 Medical Center Drive Rockville MD 20850 USA

2. Centre for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology (IIOAB) Nonakuri, Purba Medinipur West Bengal-721172 India dr.barh@gmail.com

3. Departamento de Biologia Geral, Instituto de Ciências Biológicas (ICB), Universidade Federal de Minas Gerais Pampulha Belo Horizonte Minas Gerais Brazil

Abstract

In this chapter we discuss the challenges in cancer biomarkers discovery. Furthermore, we discuss next-generation molecular markers and their applications in diagnostic screening, early diagnosis, risk assessment, prognosis and pharmacogenomics of immune diseases, cardiovascular diseases, metabolomic diseases, infectious diseases, neurological diseases and cancers. Additionally, we give brief accounts of therapeutic biomarkers for these selected diseases. Finally, we conclude the chapter with a future perspective on molecular biomarkers.

Publisher

The Royal Society of Chemistry

Link

https://books.rsc.org/books/edited-volume/chapter-pdf/1560359/bk9781782628217-00494.pdf

Reference161 articles.

1. Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance

2. Opportunities and Challenges for Selected Emerging Technologies in Cancer Epidemiology: Mitochondrial, Epigenomic, Metabolomic, and Telomerase Profiling

3. A Bead-Based Multiplexed Immunoassay to Evaluate Breast Cancer Biomarkers for Early Detection in Pre-Diagnostic Serum

4. A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer

5. Epigenetic Biomarkers in Cancer Epidemiology